INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Indo US Bio-Tech Performance
- Low
- ₹131
- High
- ₹141
- 52 Week Low
- ₹105
- 52 Week High
- ₹206
- Open Price₹141
- Previous Close₹141
- Volume33,789
- 50 DMA₹131.64
- 100 DMA₹133.07
- 200 DMA₹150.29
Investment Returns
- Over 1 Month + 8.82%
- Over 3 Month + 3.69%
- Over 6 Month -6.31%
- Over 1 Year -28.24%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.5
- PEG Ratio
- 1.4
- Market Cap Cr
- 274
- P/B Ratio
- 3.1
- Average True Range
- 8.35
- EPS
- 7.4
- Dividend Yield
- 0
- MACD Signal
- 5.39
- RSI
- 55.49
- MFI
- 66.56
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹136.51
-4.2
(-2.98%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹137.65
- 50 Day
- ₹131.64
- 100 Day
- ₹133.07
- 200 Day
- ₹150.29
Resistance and Support
142.34
- R3 156.07
- R2 152.04
- R1 146.37
- S1 136.67
- S2 132.64
- S3 126.97
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-21 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹136 As on 04 March, 2026 | 13:58
The Market Cap of Indo US Bio-Tech is ₹273.7 Cr As on 04 March, 2026 | 13:58
The P/E ratio of Indo US Bio-Tech is 18.5 As on 04 March, 2026 | 13:58
The PB ratio of Indo US Bio-Tech is 3.1 As on 04 March, 2026 | 13:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.